Biodefense countermeasures: the impact of Title IV of the US Pandemic and All-Hazards Preparedness Act

Article English OPEN
Gronvall, GK (2011)

The 2006 US Pandemic and All-Hazards Preparedness Act gave the Department of Health and Human Services (HHS) new authority to fund the development and procurement of medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) threats. The legislation builds on the authority the HHS gained in 2004 under Project BioShield, which established a fund to procure medical countermeasures. This article reviews the new HHS authorities and the improvements on BioShield, and it describes some of the challenges HHS will face in exercising the new authorities to fund the development and procurement of medical countermeasures against CBRN threats. (Published: 29 February 2008) Emerging Health Threats Journal 2008, 1:e3. doi: 10.3134/ehtj.08.003
  • References (32)
    32 references, page 1 of 4

    1 United States Congress House. Committee on Government Reform. Project BioShield: contracting for the health and security of the American public: hearing before the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, 4 April 2003. In: U.S. G.P.O.: Washington, 2003. p iii, 128pp.

    2 A bill to amend the Public Health Service Act with respect to public health security and all-hazards preparedness and response, and for other purposes: 'Pandemic and All-Hazards Preparedness Act'. In: Public Law No: 109-417, 2006.

    3 Library of Congress. The Newshour with Jim Lehrer. State of the Union address. 28 January 2003. PBS: USA, 2003.

    4 An Act to amend the Public Health Service Act to provide protections and countermeasures against chemical, radiological, or nuclear agents that may be used in a terrorist attack against the United States by giving the National Institutes of Health contracting flexibility, infrastructure improvements, and expediting the scientific peer review process, and streamlining the Food and Drug Administration approval process of countermeasures. 'Project BioShield Act of 2004'. In: Public Law 108-276. 108th Congress edn. 2004.

    5 Gottron F. Project BioShield: appropriations, acquisitions, and policy implementation issues for Congress. Congressional Research Service, 8 March 2007.

    6 Russell PK. Project BioShield: what it is, why it is needed, and its accomplishments so far. Clin Infect Dis 2007;45 (Suppl 1): S68-S72.

    7 Department of Health and Human Services. Procurement Activities. 5 June 2007; available at barda/procurement/bioshield.html, accessed 12 June 2007.

    8 Small Business Innovation Research program. Available at http://, accessed 8 October 2007.

    9 Pharmaceutical Research and Manufacturers Association. Press Release: PhRMA's Statement on Senate Passage of S. 15, 'Project Bioshield Act of 2004', 19 May 2004.

    10 Department of Health and Human Services. 'Termination LetterFContract No. HHSO1002005000001C,' Letter to VaxGen Inc., 19 December 2006.

  • Metrics
    No metrics available
Share - Bookmark